Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Schering licenses Epix IP

Schering received a royalty-bearing license to EPIX's European Patent No. 222,886 and U.S.

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE